In this paper, we report a family with compensated chronic haetive staining for iron and was normoplastic with slightly leftmolysis where the only erythrocyte abnormality detected was shifted erythropoiesis consistent with haemolysis. Chromo- 
Introduction and the spleen was found to be enlarged (700 g) but normal by microscopy. The splenectomy was without effect on the Severe erythrocyte pyrimidine 5′-nucleotidase deficiency is intensity of haemolysis (follow-up time 5 years) but resulted in associated with chronic haemolysis and accumulation of very persistent thrombocythemia 600-700 × 10 9 /1 (150-400). The high concentrations of various pyrimidine nucleotides includgall bladder and several pigmented stones were removed at ing CDP-choline in erythrocytes. [1] [2] [3] [4] the age of 22 years. A single case of haemolytic anaemia with an isolated accumulation of erythrocyte CDP-choline and normal activity of pyrimidine 5′-nucleotidase has been reported previously. 5 
Preparation of blood for investigation
The most likely explanation for the selective accumulation of CDP-choline is a deficiency of choline phosphotransferase, Blood was drawn by venipuncture into heparinized tubes after the enzyme which catalyses the final step in lecithin syninformed consent and extracted immediately with two parts thesis. 5, 6 As this enzyme is not present in mature erythrocytes, of ice cold 2 M perchloric acid (PCA) essentially as the defect was inferred to be located in haemopoietic bone described. 7, 8 The neutralised extracts were then lyophilised for marrow cells. 5 It could not be established whether the defect NMR measurements. was inherited or acquired.
Aliquots of the blood were also extracted for the enzymatic We report here a family with chronic haemolysis and isodetermination of 2,3-diphosphoglycerate (2,3-DPG) 9 as lated accumulation of erythrocyte CDP-choline as detected described earlier. 8 Pyrimidine 5′-nucleotidase activity was and identified by 31 P-NMR spectroscopy. assayed as described 1 on leucocyte-depleted blood. 10 
P-NMR measurements

Materials and methods
The neutralised and lyophilised extracts were redissolved in Clinical summary of proband 2.5 ml 20% D 2 O, 50 mM CDTA, and pH was adjusted to 7.5 before obtaining 31 P-NMR spectra at 101.3 MHz, using preThe patient was referred at the age of 20 years because of viously published parameters. 7, 8 Phosphorylated metabolites clinical and laboratory evidence of jaundice that had become were quantified by using the 2-phosphorous peak of 2,3-DPG gradually apparent during the previous 2 years. Apart from a as an internal standard. 2,3-DPG was determined enzycomplicated right crural fracture at age 16, the clinical history matically. 9 The 31 P-NMR spectra were referenced to 85% was uneventful. The following laboratory tests were found to 
Family record
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Three members of the family, the mother and two male chil- sated haemolytic anaemia (Table 1 ). A third male child was not available for investigation. The mother had a long clinical history of unexplained compensated haemolytic anaemia dating back to 1971. The family history (pedigree, Figure 1 ) revealed that the proband's maternal great-grandmother had symptoms of jaundice and gallstones. A maternal uncle had the same symptoms of haemolytic anaemia. The mother of the proband has two other brothers and one sister, all without symptoms. The maternal grandmother and grandfather of the proband were without any symptoms of haemolytic anaemia. The family history of the father did not reveal any members with symptoms of haemolytic anaemia.
Identification and quantification of CDP-choline
P-NMR spectrum at 101.3 MHz of a neutralised perchloric acid extract of erythrocytes from the proband is shown in Figure 2 . This spectrum is qualitatively and quantitatively similar to that from a normal control except for the increased size of the doublet at −11.25 p.p.m. labelled X (Figure 2 ). As shown in the inset spectrum in Figure 2 , where the region from −9.8 to −11.5 p.p.m. has been amplified and the resolution enhanced, the unidentified peak was in fact a quartet, pound with the same chemical shifts and coupling pattern is CDP-choline. 3 The set of peaks were identified conclusively as CDP-choline by adding the pure compound to the extract from the proband (Figure 3a and c) .
The concentration of CDP-choline in erythrocytes from the family was measured by 31 P-NMR, and the results are given in Table 2 . Included in the table are the levels of 2,3-DPG, measured enzymatically, and the concentrations of ATP and ADP determined by 31 P-NMR. As shown in Table 2 , the proband, a brother, and the mother all had elevated erythrocyte levels of CDP-choline as compared to the father and a reference population. The concentrations of adenine nucleotides and 2,3-DPG were all within the normal range (Table 2) . To exclude the possibility of pyrimidine 5′-nucleotidase deficiency, the activity of this enzyme was measured with both UMP and CMP as substrates in haemolysates from the
Figure 1
Pedigree of the family with the arrow indicating the proband.
proband (Table 3) . The results of pyrimidine 5′-nucleotidase 
Discussion
Pyrimidine 5′-nucleotidase deficiency is recognised as a leading cause of hereditary non-spherocytic haemolytic anaemia. 11 This disease is characterised by accumulation of pyrimidine nucleotides in erythrocytes from affected individuals, [1] [2] [3] [4] and easily recognised by 31 P-NMR spectroscopy.
3,4
CDP-choline is one of several cytidine compounds which accumulate in erythrocytes from individuals affected by pyrimidine 5′-nucleotidase deficiency. 3 A single case of chronic haemolysis with selective accumulation of erythrocyte CDP-choline and with a normal activity of pyrimidine 5′-nucleotidase has previously been reported 5 but it was not ascertained whether the defect, detected in a 17-year-old girl, was inherited, nor was CDP-choline identified and quantitated by 31 P-NMR spectroscopy.
Here we report a family with chronic haemolysis and with selective accumulation of erythrocyte CDP-choline (Figures 1  and 2 ; Tables 1 and 2 ). Both the proband and his mother had a long history of unexplained haemolytic anaemia.
A 31 P-NMR spectrum of erythrocytes from the proband revealed increased levels of a doublet at −11.25 p.p.m. (Figure 2 ). The peak was subsequently identified by 31 P-NMR spectroscopy as CDP-choline (Figure 3 ). This finding prompted an investigation of the family, where the proband, his brother, and his mother were all found to have increased (Table 2) .
of CDP-choline (a) erythrocytes from the proband without (b) and with added CDP-choline (c) (arrows). PCr in the bottom spectrum denotes Furthermore, they all showed clinical and laboratory signs of phosphocreatine that was used as a reference in the model solution.
haemolytic anaemia (Table 1 ). In subjects with pyrimidine 5′-Other peak identifications are as in Figure 1. nucleotidase deficiency there is an accumulation of pyrimidine phosphates 1,2 which are easily detected by 31 P-NMR spectroscopy.
3, 4 The affected persons reported showed no evidence of accumulation of pyrimidine di-and triphosphates Table 2 Concentrations of CDP-choline, 2,3-DPG, ATP, and ADP characteristic of pyrimidine 5′-nucleotidase deficiency in their in erythrocytes from the proband, the family, and from normal erythrocytes (Figures 2 and 3) . Furthermore, pyrimidine 5′-controls nucleotidase activity in haemolysates from the proband was found to be similar to a normal control and a published refer-CDP-choline 2,3-DPG ATP ADP ence interval (Table 3) . caused by defects other than pyrimidine 5′-nucleotidase deficiency. Increased levels of CDP-choline in erythrocytes have been reported from uraemic subjects, 12 but no members of the family presented here had clinical signs of nephropathy, and the proband had a normal level of plasma creatinine.
The enzymatic defect that causes the accumulation of CDPactivity in haemolysates from the proband and a haematologically normal, internal control were both within a published choline in this family is unclear. A defect in choline phosphotransferase, the final step in lecithin synthesis, is the most reference interval (Table 3 ). in pyrimidine 5′-nucleotidase deficiency. Br J Haematol 1979; 43:
likely cause, as was also concluded in a similar case published 423-434. previously. 5 The results presented here strongly indicate a her-
